|
20
Jul 2004 – Nova is releasing VESALIUS-OTM (Operating Theatre
Management) V7.0 with two new modules included as part of the standard
package.
Since the recognition that human immunodeficiency virus (HIV)
is transmissible by blood transfusion there has been increasing
public and professional support for autologous blood donations
before elective surgery. Autologous blood donation is, however,
a more expensive process than the donation of allogeneic blood
by community volunteers, hence the management of this process is
important.
It is for this reason that Nova incorporated the Autologous Blood
Collection module - to record the blood collection and transfusion
status for operations that require autologous blood. This is to
ensure that blood collections and withdrawals are properly scheduled.
Another module, Big Board View was developed
to primarily keep track of the patient’s location movement within the operating
theatre, e.g. Preparation Area, OT, Recovery Room, ICU and Ward.
Like a flight information display in an airport, the Big Board
View provides an overview of the patient’s progress and movements
within the surgical environment. Refreshed at the pre-defined frequency,
the results can be projected onto LCD screens located strategically
in the OT as well as waiting area for relatives.
Besides the 2 new modules, Nova has also incorporated another resource-optimizing
feature in the product. Instead of a fixed duration for a surgery,
the length of surgery used in the booking will be based on historical
data collected in the database and is surgeon-specific. In other
words, the system will compute the previous, say six similar
procedures and provide an accurate estimate for the surgeon involved.
Nova’s VESALIUS-OTM is dedicated to providing
the industry a suite of products aimed at improving the delivery
of care to
the patients, from the time they are scheduled for a surgical
procedure up to the time they recover at the wards.
__________________________________________________________________________________
Please direct all queries related to this article
to Marketing at enquiry@nova-hub.com
__________________________________________________________________________________
<
back to novaNEWS |